<SEC-DOCUMENT>0001178913-17-002962.txt : 20171101
<SEC-HEADER>0001178913-17-002962.hdr.sgml : 20171101
<ACCEPTANCE-DATETIME>20171101161957
ACCESSION NUMBER:		0001178913-17-002962
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171101
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171101
DATE AS OF CHANGE:		20171101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Integrity Applications, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54785
		FILM NUMBER:		171169197

	BUSINESS ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		19 HA'YAHALOMIM ST
		STREET 2:		P.O. BOX 12163
		CITY:			ASHDOD
		STATE:			L3
		ZIP:			L3 7760049
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk1720700.htm
<DESCRIPTION>8-K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.3.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">UNITED STATES</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Washington, D.C. 20549</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">FORM 8-K</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CURRENT REPORT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Pursuant to Section 13 or 15(d) of the</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Securities Exchange Act of 1934</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date of Report (Date of earliest event reported):&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>November 1</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>, 2017</u></font></u></font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z0be9286b100941c39176a8407f2f67cb" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 16pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: bold; FONT-STYLE: normal; WIDTH: 100%">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Integrity Applications, Inc.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Exact name of registrant as specified in its charter)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zb58beda15e124ce8a47984f888e3ac78" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 34.62%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Delaware</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 31.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">0-54785</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 33.65%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">98-0668934</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 34.62%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(State or Other Jurisdiction</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 31.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Commission</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.65%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(IRS Employer</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 34.62%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">of Incorporation)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 31.73%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">File Number)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 33.65%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Identification No.)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z60604f34a8c74f1c9032238c79acd6fe" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 48.08%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">19 Ha&#8217;Yahalomim St., P.O. Box 12163, Ashdod, Israel</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 51.92%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">L3 7760049</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 48.08%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Address of principal executive offices)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 51.92%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Zip Code)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Registrant&#8217;s telephone number, including area code:&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>972 (8) 675-7878</u></font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="ze0cffd66bf3f48a9b4ebe77f7bc2e8af" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">N/A</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Former name or former address, if changed since last report)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zbb959c68fc394825b2e759fdd9874514" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 4.55%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 95.45%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167; 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167; 240.12b-2).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Emerging growth company&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Section 7 &#8211; Regulation FD</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 7.01. Regulation FD Disclosure</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">November 1</font>, 2017,&#160;Integrity Applications, Inc.&#160;&#160;(the &#8220;Company&#8221;) published a press release regarding&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a re-order that the Company received</font> from <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">an existing customer.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">A copy of</font> the press release <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">is</font> attached hereto as <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Exhibit</font> 99.1<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font> The information contained in this item and the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">exhibit</font> attached herewith shall be deemed furnished and not filed.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Section 9 &#8211; Financial Statements and Exhibits</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Item 9.01. Financial Statements and Exhibits</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z6cfd63d2274e4abc9ad63802f249de7c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Exhibit&#160;No.</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2.88%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 89%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Description</div>
</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="VERTICAL-ALIGN: top; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_99-1.htm">99.1</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2.88%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_99-1.htm">Press Release, dated November 1, 2017</a></div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div id="DSPFPageFooter"></div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SIGNATURES</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Date:&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">November 1</font>, 2017

<div id="DSPFPageFooter">&#160;</div>
</div>

<table id="z8c8308302e9e412d81b2659d521724ba" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">INTEGRITY APPLICATIONS, INC.&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">By:</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;/s/ John Graham</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Name:&#160; John Graham</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Title:&#160; &#160; Chief Executive Officer</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.3.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div>&#160;</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: right; FONT: bold 10pt/1.25 'Times New Roman', Times, serif"><u>Exhibit 99.1</u></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><img style="HEIGHT: 101px; WIDTH: 310px" src="image0.jpg"></div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: center; FONT: bold 12pt/1.25 'Times New Roman', Times, serif">Integrity Applications Announces Re-Order of GlucoTrack&#174; Devices</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Wilmington, DE and Ashdod, Israel</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> &#8211; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">November 1 2017 - </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Integrity Applications, Inc. </u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(OTCQB: IGAP) (&#8220;Integrity&#8221; or the &#8220;Company&#8221;), innovator of GlucoTrack&#174;, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced that it has received the largest single re-order of GlucoTrack&#174; to date. The recent order of GlucoTrack&#174;, in the amount of US$460,000, was a re-order from an existing customer and represents a nearly two-fold increase from the original order. The purchase order was paid in full in advance of delivery, which is expected to be completed within the next four to six weeks with all revenue being recognized in 2017.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Dave Podwalski, Integrity&#8217;s Chief Commercial Officer commented, &#8220;We are extremely pleased with this recent re-order as it demonstrates the growing acceptance and use of GlucoTrack, the Company&#8217;s focus on commercialization and the opportunity ahead for this exciting, life changing product.&#8221;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">About GlucoTrack&#174;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">GlucoTrack&#174; is a truly non-invasive monitoring device that rapidly measures and displays an individual&#8217;s glucose level in about a minute without finger pricking or any pain.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">GlucoTrack&#174; features a small sensor that clips to the earlobe and measures the user&#8217;s glucose level using innovative and patented sensor technologies. The measured signals are analyzed using a proprietary algorithm and then a calculated glucose level is displayed on a small handheld device the size of a small mobile phone. The glucose results are stored in the device and used to estimate HbA1c level using a proprietary algorithm. The device can also display glucose values graphically, enabling the user to monitor glucose levels over time.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">GlucoTrack&#174; has received approvals for CE Mark in Europe and from the Ministry of Food and Drug Safety in South Korea for type 2 diabetes and pre-diabetics, and is currently in the early stages of commercialization in Europe, South Korea, and other geographies.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">GlucoTrack&#174; is expected to begin clinical trials for United States FDA approval. The product is currently experimental in the United States and is limited to investigational use only.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">About Integrity Applications, Inc.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Integrity Applications, Inc. (OTCQB: IGAP) was founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. The Company has developed GlucoTrack&#174;, a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements in about a minute without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices. Integrity Applications Inc. is a Delaware corporation, with headquarters in the United States and an R&amp;D site in Ashdod, Israel. For more information, please visit <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.integrity-app.com/</u></font> and <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>http://www.glucotrack.com</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Forward-Looking Statements</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as &#8220;expect&#8221;, &#8220;plan&#8221; and &#8220;will&#8221; are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect Integrity Applications&#8217; actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Integrity Applications&#8217; results include, but are not limited to, the ability of Integrity Applications to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including FDA approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to its current and future distribution agreements; risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel; and the additional risk factors described in Integrity Applications&#8217; filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), including its Annual Report on Form 10-K for the year ended December 31, 2016 as filed with the SEC on March 31, 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Media Contacts</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Tamar Lin/ Stefanie Saffern</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>tamarl@integrity-app.com</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>stefanier@integrity-app.com</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">+972.8.675.7878</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Investor Contacts</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Sami Sassoun, CFO Integrity Applications</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>SamiS@integrity-app.com</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">+972 (8) 675-7878 Ext. 400</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chiara Russo</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director, Investor Relations</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">LaVoieHealthScience</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">617-374-8800 Ext. 112</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>CRusso@lavoiehealthscience.com</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div id="DSPFPageFooter"></div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "D ?0# 2(  A$! Q$!_\0
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M[QE=FY\1S*#E8%$:_P S^I-=F I\]97Z:GF9M6=+#-+=Z&!1117T!\>%%%%
M!7>^ =2,EO/ISMDQ_O(_H>H_/'YUP5;'A>Z-IXBLVSA9'\IO?=Q_/%<^+I^T
MHM';E]9T<1&71Z/YGK%%%%?-GVP4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 44R601)D_@*HR3/(>3QZ"FE<"
M\98UZNOYTGGQ?WQ6=15<H&F)$;HP/XTZLJGK-(G1C]#1R@:5>-:I*9]6O)2<
M[YW/ZFO7$NP>'&/<5X_>120WDJ2HR.'.0PQWKTLL5I2/ SV_)#YD%%%;_A?P
M^-:N9'G++:PXW;>K$]J]2I4C3BY2V/ HT9UIJG#=F!17K7_",Z+Y/E?V?%MQ
MC/.[\^M<%XGT#^Q+Q#$S-;39*%NJD=0:YZ&-IUI<JT9VXK*ZV'A[1M->1A5)
M!(8;B.4=48,/P-1T5U[GG)V=SW '(R.AHK'N]?L]/@1&;S9PHS&G8X[GM7.7
MGB:_N21&PMT](^OY_P"&*^8C2E(_04[H[B26.%=TLB(OJS8%4WUK34.#>PG_
M '6S_*O/))'E<O([.QZECDTVM5AUU8ST5-;TQS@7L0^IQ_.KD<L<R[HI$D7U
M5@17EU20SS6\@DAD>-QW4XH>'71@>H45SFA^(S=2+:WF!,>$D' ;V/O71USR
MBXNS ****D HKQSQW\:9]!UZ?2-#L;:=[5MD\]SN*EQU554CITR3USQ74?#?
MXC1^.;6XBGMEM=1M0#)&C91U/\2YY'/!'TYYH [NBBB@ HHHH **** "BBL^
M_P!=TC2I%CU'5;&S=QE5N+A(RWT#$4 :%%,BECGB66&19(W&5=#D,/4&GT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45XUXX^-EQHFOW&DZ'
M8VTYM',<\]SN(+C[RJJD=#QDGKGBNL^''Q$B\=65PLMLMKJ%K@RQJV593T9<
M\]N1VXYYH [FBBJ.H:UI6D[/[2U.SL]_W?M,ZQ[OIN(S0!>HJ."XANH$GMYH
MYH7&5DC8,K#V(ZU)0 4444 %%%% !1110!0N7W3$=EX%0T^7B9_]XTRM5L 4
M444 %%%% !63J%A;WZM'<1[L$[6'#+]#6M52<8E/OS5TY.+NC*M",XVDKHX#
M5-(GTU\GYX6/RR ?H?0UU7P_O(O(NK(D"7?YJC^\,8/Y8_6KTL231-%*@=&&
M&4]ZXO4K"?1;Y9;>1U0G,4JG!'L??^=>DJBQ--TI:,\"I0> K+$4U>/5=CUN
MN'^(%Y$1:6:D&129&_V1T'Y\_E6*?&6MF'R_M2YZ;_+7=_*L6226XF:21VDD
M<Y+,<DGZU.&P,J=3GF]@QV:PKTG2I)Z]Q@!8X'6I8U'F*JGYBV-W^%-.%&U?
MQ/K_ /6J6T3?<+QPO)_S]:Z:M9O1;%8'+U"TZBN_R-.BBBN ^B"BBB@ HHHH
M 4$J002".017I&EW1O=,M[AOO,OS?4<']17FU=]X;4KH5OGN6(_[Z-88A>[<
M#6HHHKD ^<_B-\+?$">*[[4M)L9+^SOIFG!AY:-F.64KUZDX(XQ7:_!SP!J?
MA@7FJZQ'Y%S<QB**WW LJ9R2V.,D@<>U8?C[XQZSI?BB[TG1$MX8;-_*>66/
M>SN/O=>  >/PKK/A5\1+OQK#>6FIPQ)?6@5_,A!"R(<CIV((_6@#T>BLCQ1K
MB>&O#-_K$D?F"UBW*F<;F) 49[9)%>#V'QW\2QZJDU]#9S61?]Y!'%M(7OM;
M.<_7- 'T?17!>-OBIH_A&-(8E^WZC(@=;>-L!%(R"[=LCG'7Z=:\FNOCIXNG
MF+0BPMDSPB0;OU8F@#Z6HKP'0/C[J,5RD>OZ?!/;$X:6U!21??!)#?3BO=--
MU*TU?3H-0L)UGM9TWQR+T(_H?;M0!:KXQ\27]QJGB74KVZD:2:6Y<DD]!D@#
MZ 8 ^E>Z^/OC#/X5\23:+8:7%/);JAEEG<@990P  ]B.<U\]7$QN+F6=@ 9'
M+D#MDYI >^_L_7]Q/H.K64DC-!;3HT2DYV[P<@>WRY_$U[#7RAX&^(M]X%AO
M8[.RM[D7;(S&8L-NW/3'UKW3X;_$4>.X;U)K$6EU:;"P1]R.K9P1W'0\?2F!
MW=%1SSQ6T$D\\B10QJ6=W;"J!U))Z"O(/$_QYLK.=[;P]8B]93C[5.2L9/\
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MJAG@$HR.&'ZU-10!ED%3@C!%)6C+"LHYX/8U2DA>+J,CU%:)W CHHH) &2<
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MY@"BBB@#X^\>?\E \0?]?\W_ *&:] _9\_Y&'5_^O1?_ $.N \>_\E \0?\
M7_-_Z&:[_P#9\_Y&'6/^O1?_ $.D!Z9\6_\ DEVM?[L7_HU*^4J^K?BW_P D
MNUK_ '8O_1J5\I4P/KCX:_\ ).-"_P"O8?S-=57*_#7_ ))QH7_7J/YFNJH
M^/?'/_(_>(/^PC/_ .AFO0_V?/\ D/:S_P!>R?\ H5>>>.O^1^\0?]A"?_T,
MUZ'^SY_R'M9_Z]D_]"I >_U\4:G_ ,A:\_Z[O_Z$:^UZ^+_$%K)8^)-3M9E*
MR0W4J,#[,:8'LW[//_'CKW_76'^3U[57RAX!^(EWX$>]6&RBNX;O:71W*%2N
M<$$9]3V]*]X^'GQ$A\>07@^PM9W5H5+Q^9O5E;."#@>AR,>E 'S9XKL7TSQ=
MK%G("#%>2@9[C<2#^(P:[CX,:1X<U[4M3T[7+&&ZN#&DML)"1P"0X&"/53^!
MKH_C;X$GGF_X2K383)A M]&@R0%&!)[C'!], ^M>*V%_=Z7?PWUC</;W4+;H
MY$."II ?5?\ PJ_P5_T+]M_WT_\ C2'X8>"5!)\/VH Y)+-_C7E6G_'_ %J"
MV6._TFSNY5&/-1VB+>Y'(S],5SWBSXM^(?%5H]C^ZL+%^'BML[I!Z,Q.2/88
M'K3 ]8L=)^$=]JXTVSATF:]W;5C$C$,?0$G#?@37H]O:6]I:):6T$<-O&NQ(
MHU"JJ^@ Z5\;^'=+O]9\06-CIBO]KDF78R?\L\'._P!@.N?:OLZ@#XFU&RDT
MW4[NQF!$EM,\+@^JD@_RKV#X ^(+>WNM1T&>14DN"MQ;@G&\@8<?7&#^!I?C
M+\/+K^T)?%&DP--#* ;V*,99& QY@'H1U]#SWX\8AFEMYDFAD>*6-@R.C$,I
M'0@CH:0'V_7B'[0&O0-;Z9H$4@:=9#=3*#]P;2J9]SN;\O>N 7XL^.%M/LPU
MZ38!C<88R^/][;G\<YKG[FPU:]TR;Q%=K-+;R7(A:ZF8DRRL&/!/WN%.?3BF
M!FI]]?K7W!7P^GWU^M?<% 'R/\2O^2CZ[_U\G^0KKO@!_P CKJ!_ZAS?^C(Z
MY+XE_P#)1]=_Z^3_ "%=;\ /^1TU#_L'-_Z,CI ?15%%%,#X[\;_ /(^>(?^
MPE<?^C&KT?\ 9[_Y#6M?]>\?_H1KSCQO_P C[XA_["5Q_P"C&KT?]GO_ )#6
MM?\ 7O'_ .A&D![[7QOXQ_Y'?7_^PE<?^C&K[(KX^\=VLEGX^U^*52K&_F<
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M[/5Q]N ?Q!%]DW<L+<^81],XS^->[T4 5=,TZWTG2[73K12MO:Q+%&"<G"C
MS[U:HHH \D\;?!9?$6OSZOIFII:/<MOFAEC++N[L"#WZXQUSS72_#SX>6_@2
MTN2;LW=[=%?-EV;5"C.%49/J>>_%=M10 5Y]XX^$VD^,;PZC'</I^I, 'F1
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M'%CX%BGD2Y>\OK@!9)V38 HYVJN3@9]ST%=K10 5\]_'[2(K7Q'IVJQE0][
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M'D<QY].XKGJD@F:WN(YD^\AS45(<T;&E*HZ<TSNZ*;'(LL22*<JP!%.KSCV
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***XS6/$6HV?Q2\.Z##(@L+
MZWFDG0H"251R,'J.5% '9T45FZ\NJMH=TNAO"FI%1Y#3?<!R,Y_#- &E1573
M1>#2[,:@R-?"!!<&/[IDVC=CVSFK5 !1110!%=6MO>VTEM=01SP2#:\<BAE8
M>A!ZUYMK'P,\+ZA(TMC)=Z:['.R)P\?Y-D_D:].HH \2_P"&>(=^?^$EDV>G
MV(9_/?\ TKI-"^"7A;29EGO/M&IRJ<A;A@(\_P"Z.OT)(KTFB@!L<:11K'&B
MI&@"JJC  '0 4ZBL,^*;%?&2^%S%<?;FM?M0DVKY>W.,9SG/X4 ;E%%5[\71
MTVZ%B46\,+^07^Z),';GVSB@"Q169X?75TT*U777A?4P#Y[0_<)W'&.!VQ6G
M0 4444 %%%% !1110!QWC'X::#XSG2ZO1/;WJ+L%Q;L 6'8,""#_ #]ZYW3?
M@/X9L[E9KRZOKY5.?*=U1#]=HS^1%>IT4 16UM!9VT=M;0I#!$H2..-<*H'0
M 5+110 4444 %%%% %2];A5]>:IU9O?]:O\ NU6KHA\)SS^(****H@**** "
MBBI8(3*^/X1U-)NPTKZ%'5VG&FQJ!^Z+_,?Y?AUK KNY8(YX&A=<HPP17&7M
MI)97+1/]5;^\/6KH335C#%4VGS="O11170<@4444 %%%% '6:%,9=,4$\QL5
M_K_6M.L/PT3]GG'8./Y5N5Y]56FSUZ#O33"BBBLS4**** .0\8P^*=1U#2]+
MT*5["PF9FO\ 48]I>)0.%4$YR>>0/3GK7*W=]JG@CQ;X?MX/%=QK5CJ=V+6X
MMKQUD>,L0 P(Y'WO;IWJ'XCSPS?$32=.\37ES:^%)+8L?+9ECEERW#E?^ _0
M'MDFN;\4W/@VPUCPW=>&+%%T[3]2BDOM0@B=D'S*0F\\L<*QQ0!]!U!>NT=A
M<.APRQ,0?0X-+:74-]9P7=L_F03QK+&^"-RL,@\^QIFH?\@RZ_ZXO_(T >1^
M!+?QGX[\.+>W_BN[L+..1HXC;(!+.0>69O09V@>WY[7AO6M?\/?$#_A#/$&H
M?VG#=0&>PO'3;(0,DJWKPK=<]/>N>^$_Q TG0O"<6DZ[*UAL=Y+6:2-O+F0L
M<X('4-N'Y5IZ3>CQ[\8+;7],CD.BZ-;-$MTZ%1-(P88&>?X^G^S[B@#UFN&^
M+6L:AH?@:6]TRZ>VN1<1J)$QG!/(KN:\X^-__).)O^OF+^9H 2+PCXTU;3DU
M*[\:7=CJ<R"1;6WC"P0DC(0C/S8Z$_S[Z7PV\5:AXATV_LM951J^E7)MKHH
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M$4 $^M/HH *K7.GV5XZ/=6EO.R?<:6(,5^F1Q5FB@ I&4,I5@"I&"".M+10
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I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
